Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs

Clara M. Bien, Yun C. Chang, W. David Nes, Kyung J. Kwon-Chung, Peter J. Espenshade

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

In the human fungal pathogen Cryptococcus neoformans, the SREBP orthologue Sre1 is important for adaptation and growth in nutrient-limiting host tissues. In this study, we characterize the C. neoformans serotype A Sre1 and its activating protease, Stp1. We demonstrate that Stp1 is a functionally conserved orthologue of the mammalian Site-2 protease and that Stp1 cleaves Sre1 within its predicted first transmembrane segment. Gene expression analysis revealed that Stp1 is required for both Sre1-dependent and Sre1-independent gene transcription, indicating that other substrates of Stp1 may exist. Using gas chromatography, we showed that Sre1 and Stp1 are required for both normoxic and hypoxic ergosterol biosynthesis, and therefore cells lacking SRE1 or STP1 are defective for growth in the presence of low levels of the ergosterol biosynthesis inhibitors, itraconazole and 25-thialanosterol. Importantly, our studies demonstrated fungicidal effects of itraconazole and 25-thialanosterol towards sre1Δ and stp1Δ cells, demonstrating that the Sre1 pathway is required for both growth and survival in the presence of sterol biosynthesis-inhibiting antifungal drugs. Given the need for fungicidal drugs, we propose that inhibitors of Stp1, Sre1, or other regulators of Sre1 function administered in combination with a sterol synthesis inhibitor could prove an effective anticryptococcal therapy.

Original languageEnglish (US)
Pages (from-to)672-690
Number of pages19
JournalMolecular Microbiology
Volume74
Issue number3
DOIs
StatePublished - Nov 1 2009

Fingerprint

Azoles
Cryptococcus neoformans
Virulence
Ergosterol
Peptide Hydrolases
Itraconazole
Sterols
Survival
Growth
Pharmaceutical Preparations
Gas Chromatography
Gene Expression
Food
Genes
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Microbiology

Cite this

Bien, Clara M. ; Chang, Yun C. ; Nes, W. David ; Kwon-Chung, Kyung J. ; Espenshade, Peter J. / Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs. In: Molecular Microbiology. 2009 ; Vol. 74, No. 3. pp. 672-690.
@article{ca50b6930423451cb772fd6ba8985bf9,
title = "Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs",
abstract = "In the human fungal pathogen Cryptococcus neoformans, the SREBP orthologue Sre1 is important for adaptation and growth in nutrient-limiting host tissues. In this study, we characterize the C. neoformans serotype A Sre1 and its activating protease, Stp1. We demonstrate that Stp1 is a functionally conserved orthologue of the mammalian Site-2 protease and that Stp1 cleaves Sre1 within its predicted first transmembrane segment. Gene expression analysis revealed that Stp1 is required for both Sre1-dependent and Sre1-independent gene transcription, indicating that other substrates of Stp1 may exist. Using gas chromatography, we showed that Sre1 and Stp1 are required for both normoxic and hypoxic ergosterol biosynthesis, and therefore cells lacking SRE1 or STP1 are defective for growth in the presence of low levels of the ergosterol biosynthesis inhibitors, itraconazole and 25-thialanosterol. Importantly, our studies demonstrated fungicidal effects of itraconazole and 25-thialanosterol towards sre1Δ and stp1Δ cells, demonstrating that the Sre1 pathway is required for both growth and survival in the presence of sterol biosynthesis-inhibiting antifungal drugs. Given the need for fungicidal drugs, we propose that inhibitors of Stp1, Sre1, or other regulators of Sre1 function administered in combination with a sterol synthesis inhibitor could prove an effective anticryptococcal therapy.",
author = "Bien, {Clara M.} and Chang, {Yun C.} and Nes, {W. David} and Kwon-Chung, {Kyung J.} and Espenshade, {Peter J.}",
year = "2009",
month = "11",
day = "1",
doi = "10.1111/j.1365-2958.2009.06895.x",
language = "English (US)",
volume = "74",
pages = "672--690",
journal = "Molecular Microbiology",
issn = "0950-382X",
publisher = "Wiley-Blackwell",
number = "3",

}

Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs. / Bien, Clara M.; Chang, Yun C.; Nes, W. David; Kwon-Chung, Kyung J.; Espenshade, Peter J.

In: Molecular Microbiology, Vol. 74, No. 3, 01.11.2009, p. 672-690.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs

AU - Bien, Clara M.

AU - Chang, Yun C.

AU - Nes, W. David

AU - Kwon-Chung, Kyung J.

AU - Espenshade, Peter J.

PY - 2009/11/1

Y1 - 2009/11/1

N2 - In the human fungal pathogen Cryptococcus neoformans, the SREBP orthologue Sre1 is important for adaptation and growth in nutrient-limiting host tissues. In this study, we characterize the C. neoformans serotype A Sre1 and its activating protease, Stp1. We demonstrate that Stp1 is a functionally conserved orthologue of the mammalian Site-2 protease and that Stp1 cleaves Sre1 within its predicted first transmembrane segment. Gene expression analysis revealed that Stp1 is required for both Sre1-dependent and Sre1-independent gene transcription, indicating that other substrates of Stp1 may exist. Using gas chromatography, we showed that Sre1 and Stp1 are required for both normoxic and hypoxic ergosterol biosynthesis, and therefore cells lacking SRE1 or STP1 are defective for growth in the presence of low levels of the ergosterol biosynthesis inhibitors, itraconazole and 25-thialanosterol. Importantly, our studies demonstrated fungicidal effects of itraconazole and 25-thialanosterol towards sre1Δ and stp1Δ cells, demonstrating that the Sre1 pathway is required for both growth and survival in the presence of sterol biosynthesis-inhibiting antifungal drugs. Given the need for fungicidal drugs, we propose that inhibitors of Stp1, Sre1, or other regulators of Sre1 function administered in combination with a sterol synthesis inhibitor could prove an effective anticryptococcal therapy.

AB - In the human fungal pathogen Cryptococcus neoformans, the SREBP orthologue Sre1 is important for adaptation and growth in nutrient-limiting host tissues. In this study, we characterize the C. neoformans serotype A Sre1 and its activating protease, Stp1. We demonstrate that Stp1 is a functionally conserved orthologue of the mammalian Site-2 protease and that Stp1 cleaves Sre1 within its predicted first transmembrane segment. Gene expression analysis revealed that Stp1 is required for both Sre1-dependent and Sre1-independent gene transcription, indicating that other substrates of Stp1 may exist. Using gas chromatography, we showed that Sre1 and Stp1 are required for both normoxic and hypoxic ergosterol biosynthesis, and therefore cells lacking SRE1 or STP1 are defective for growth in the presence of low levels of the ergosterol biosynthesis inhibitors, itraconazole and 25-thialanosterol. Importantly, our studies demonstrated fungicidal effects of itraconazole and 25-thialanosterol towards sre1Δ and stp1Δ cells, demonstrating that the Sre1 pathway is required for both growth and survival in the presence of sterol biosynthesis-inhibiting antifungal drugs. Given the need for fungicidal drugs, we propose that inhibitors of Stp1, Sre1, or other regulators of Sre1 function administered in combination with a sterol synthesis inhibitor could prove an effective anticryptococcal therapy.

UR - http://www.scopus.com/inward/record.url?scp=70350397502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350397502&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2958.2009.06895.x

DO - 10.1111/j.1365-2958.2009.06895.x

M3 - Article

VL - 74

SP - 672

EP - 690

JO - Molecular Microbiology

JF - Molecular Microbiology

SN - 0950-382X

IS - 3

ER -